Izote Biosciences is a biotechnology research company based in Berkeley, CA, specializing in oxygen-free industrial fermentation. The company manufactures high-performance small molecules and proteins for the fragrance, pharmaceutical, and specialty chemical industries. Izote Biosciences has developed a proprietary fermentation method that uses an alternative molecule 100,000 times more soluble than oxygen, eliminating the need for traditional tank aeration. This breakthrough technology offers significant economic advantages for small molecule and protein manufacturing.

Izote Biosciences

Our fermentation method uses an alternative molecule that is 100,000x more soluble than oxygen.  This molecule dissolves in the cell media, removing the need for tank aeration via air compressors, blowers, and agitators.

We manufacture high performance small molecules and proteins for the fragrance, pharmaceutical, and specialty chemical industries.

We are excited to announce Izote Biosciences’ PreSeed funding led by Embark Ventures and EGB Capital with participation from Bee Partners, FTW Ventures, Nucleus Capital, Courtyard Ventures, Climate Capital, and Redstick Ventures!

Born out of John Coates' microbiology lab at University of California, Berkeley, our breakthrough, oxygen-free fermentation system offers step-change economics for small molecule and protein manufacturing. This financing will accelerate the development of our core technology: proprietary microbes that can “breathe without air”.

Special thanks to Kira Noodleman of Bee Partners for connecting our co-founders, Victor Manuel Reyes-Umaña and Samuel Atwood, and supporting the team from day one.

Read about us in TechCrunch!

IZOT

BIO:IZOTE

Izote Biosciences